DINAMICS OF THE DIABETIC FOOT. CLINICAL OUTCOMES (DIABETIC FOOT) IN HYPERTENSIVES WITH TYPE 2 DIABETES BEFORE AND AFTER IMPLEMENTATION OF GUIDELINES ON MANAGEMENT IN KAZAKHSTAN
https://doi.org/10.15829/1560-4071-2016-5-140-145
Abstract
Aim. To analyze the dynamics or diabetic foot prevalence depending on the sex of patients. To study clinical outcomes of diabetic foot in hypertensives with diabetes type 2 (DM) before and after implementation of the management protocols (MP) for arterial hypertension (AH) and DM. Material and methods. Totally, data on 13737 patients included, from SouthKazakhstan region (SKR), and 118131 patients aged 18 y. o. and older. The study was done based on the retrospective database analysis of Republic Center of Healthcare development of the Ministry of Health and Social development of Kazakhstan Republic (RK) from 2000 to 2014 y. Results. The number of clinical outcomes as diabetic foot in AH with DM patients among males 18 y. o. and older, remained almost unchanged in SKR during the studied period (2000-2014), and in RK the number reduced, respectively, from 9,7% to 7,4% (p>0,05). Conclusion. After implementation of diagnostics and management protocols, in 2006-2014y. there was decrease of the part of diabetic foot cases, of disability and mortality among the patients with AH and DM, both sexes, in SKR and in the entire RK.
About the Authors
Zh. Akimbaeva
Asfendiyarov KazNMI
Kazakhstan
Kazakhstan
Zh. Akanov
Asfendiyarov KazNMI
Kazakhstan
Kazakhstan
Т. Meimanaliev
The Medical Insurance Foundation of the Kyrgyz Republic Government
Kyrgyzstan
Kyrgyzstan
References
1. Bakris G, Fonseca V, Katholi R, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA, 2004; 292: 2227-34.
2. IDF Diabetes Atlas. Sixth edition. 2013. 153 p.
3. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med, 2001; 249: 225-35
4. World Health Organization, Fact sheet № 311, Updated August 2014.
5. Bakris G. Treatment of hypertension in patients with diabetes mellitus. UpToDate, 2014.
6. Van Houtum W, Rauwerda J, Ruwaard D, et al. Reduction in diabetes-related lowerextremity amputations in the Netherlands: 1991-2000. Diabetes Care, 2004; 27: 1042-6.
7. Jeffcoate W, Margolis D. Incidence of major amputation for diabetes in Scotland sets a target for us all. Diabetes Care, 2012; 35: 2419-20.
8. Li Y, Edmonds M, Rayman G, et al. Declining rates of hospitalization for nontraumatic lowerextremity amputation in the diabetic population aged 40 years or older: US, 1988-2008. Diabetes Care, 2012; 35: 273-7.
9. Peters E, Lavery L. Effectiveness of the diabetic foot risk classification system of the international group on the diabetic foot. Diabetes Care, 2001; 24 (8): 1442-7.
10. Department of Health Survey for England, 2007. 16 April 2010.
11. Ikonen T, Sund R, Venermo M, et al. Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study. Diabetes Care, 2010; 33: 2598-603.
12. Moss S, Klein R, Klein B. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care, 1999; 22 (6): 951-9.
Review
For citations:
Akimbaeva Zh., Akanov Zh., Meimanaliev Т. DINAMICS OF THE DIABETIC FOOT. CLINICAL OUTCOMES (DIABETIC FOOT) IN HYPERTENSIVES WITH TYPE 2 DIABETES BEFORE AND AFTER IMPLEMENTATION OF GUIDELINES ON MANAGEMENT IN KAZAKHSTAN. Russian Journal of Cardiology. 2017;(5):140-145. (In Russ.) https://doi.org/10.15829/1560-4071-2016-5-140-145
Views:
985
Email this article 